Stage migration of colorectal cancer during COVID-19 pandemic

Abstract

et al. Recommendations for general surgery activities in a pandemic scenario (SARS-CoV-2).

A Decisão Consciente Do Parto: Uma Revisão De Literatura

“…No pico da pandemia, nos Estados Unidos, no mês de abril, foi registrada queda de 75% e 74%, respectivamente, nos exames para câncer de próstata e de cólon, em relação ao ano de 2019 (PATT et al, 2020). No Reino Unido, os exames de câncer colorretal caíram 84,5%, até maio de 2020de (VOSE et al, 2020; vale ressaltar que os britânicos também perceberam que os novos diagnósticos de acesso rápido caíram em torno de 3 a 4%, o que pode ter acarretado a retirada de pacientes de alto risco da rede de rastreamento, durante esse tempo (LIYANAGE et al, 2020). Já nas regiões Norte e Central, da Itália, constatou-se redução de 46,6% nos diagnósticos de câncer colorretal e queda de 45% no diagnóstico de câncer de próstata, no ano de 2020de , em comparação com 2019de e 2018de (FERRARA et al, 2021.…”

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

“…With the documented reductions in screening measures and treatment delays occasioned by COVID-19 measures, the medical community should anticipate a general shift in colorectal cancer stage, a negative impact on survival and recurrence of the disease[ 10 , 16 , 48 , 49 , 55 , 58 , 91 , 92 ]. Therefore, there will need to be vigilant and aggressive in screening and prioritizing oncology patients as the world gears towards post pandemic normalization of the health systems albeit some reported surges in COVID-19 cases, especially in Southeast Asia[ 10 , 16 , 48 , 49 , 55 , 58 , 91 , 92 ].…”

“…Meijer et al [ 62 ] reported a reduction of patients presenting with stage I and stage II CRC from 29.5% and 26.6% to 20.0% and 25.5%, respectively, after the onset of COVID-19 pandemic. They also noticed an increase of patients with stage III and stage IV from 22.2% and 19.0% to 26.8% and 26.2%, respectively[ 16 , 62 ]. These changes were attributed to the delays in screening and diagnosis of CRC that was caused by the COVID-19 pandemic[ 17 , 55 , 62 ].…”

“…The mode of presentation was also affected by the pandemic as Shinkwin et al [ 59 ] reported an increase in emergency presentation from 28.6% to 36.0%. The increased emergency presentation was also associated with increased morbidity and mortality[ 14 , 16 , 18 , 62 ].…”

Has the COVID-19 pandemic changed the clinical picture and tumour stage at the time of presentation of patients with colorectal cancer? A retrospective cohort study

“… 24 , 25 Therefore, some authors have expressed their concern about how CRC diagnosis and treatment delay could have impacted tumour stages at presentation as well as long-term mortality. 26 The aim of this study was to analyse the diagnosis and treatment delay as well as the tumour stage of patients diagnosed with CRC and treated during the pandemic in a tertiary care hospital in Spain. The results of this cohort were compared with a cohort of patients with CRC that were treated in the same centre before the pandemic started.…”